ThinkCyte
PrivateLast Round
Grant
Aug 4, 2025
Total Funding Raised
$129.9M
Company Overview
ThinkCyte is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThinkCyte Comparables
Compare ThinkCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deepcell | 94% | |
| NanoCellect Biomedical | 81% | |
| STEMCELL Technologies | 81% |
ThinkCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 4, 2025 | ||||
| Series C | Aug 29, 2024 | ||||
| Debt | Aug 29, 2024 | ||||
| Grant | Nov 28, 2023 | ||||
| Series C | Nov 28, 2023 | ||||
Grant | Oct 18, 2023 |
Key People
Founding team and executive leadership
ThinkCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| ITOCHU Technology Ventures | Series C, Series B, Series A |
| Sumitomo Mitsui Trust Bank | Series C |
| 株式会社日本政策金融公庫 | Debt |
| New Energy and Industrial Technology Development Organization | Grant |
| Global Brain Corporation | Series C |
| Japan Investment Adviser | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2025
Added Almog Diagnostic & Medical Equipment Ltd. as a customer.
- Jun 3, 2025
Launched MorphoScan Cloud, a cloud-based platform for AI-driven cell morphology analysis.
ThinkCyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ThinkCyte's valuation, stock price, and market status.
Is ThinkCyte a public or private company?
ThinkCyte is a private company.
What is the current stock price of ThinkCyte?
ThinkCyte is a private company with no public stock price. No recent secondary market data is available.
How much is ThinkCyte worth (valuation)?
Valuation information for ThinkCyte is not publicly available.
Can I buy ThinkCyte stock?
ThinkCyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ThinkCyte's last funding round?
ThinkCyte's most recent funding round was Grant on August 4, 2025.
Who are the main investors in ThinkCyte?
Key investors in ThinkCyte include Japan Agency for Medical Research and Development, 株式会社日本政策金融公庫, Global Brain Corporation, JAPAN GREEN INVESTMENT CORP. FOR CARBON NEUTRALITY (JICN), SPARX Group.
Will ThinkCyte IPO soon?
No public IPO plans have been announced for ThinkCyte.
How can I track ThinkCyte secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ThinkCyte's secondary market activity and sign up for updates.